Merck (UKEX:MRK) Cyclically Adjusted Book per Share: ₴699.08 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UKEX:MRK Merck & Co Inc UKEX:MRK
73 GF Score
Price ₴4,844.00
GF Value ₴4,758.57
! 8 Warning Signs
View Full Analysis

What is Merck Cyclically Adjusted Book per Share?

Merck UKEX:MRK 73 Cyclically Adjusted Book per Share is ₴699.08 as of Mar. 2026. GuruFocus rates UKEX:MRK with a GF Score™ of 73/100 and a GF Value™ of ₴4,758.57. The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Merck's adjusted book value per share for the three months ended in Mar. 2026 was ₴831.303. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₴699.08 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Merck's average Cyclically Adjusted Book Growth Rate was 2.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 0.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 1.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 0.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Merck was 11.30% per year. The lowest was -1.00% per year. And the median was 6.40% per year.

As of today (2026-07-15), Merck's current stock price is ₴4844.00. Merck's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ₴699.08. Merck's Cyclically Adjusted PB Ratio of today is 6.93.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Merck was 7.82. The lowest was 3.04. And the median was 4.75.


Merck  (UKEX:MRK) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Merck's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4844.00/699.08
=6.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Merck was 7.82. The lowest was 3.04. And the median was 4.75.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Merck Cyclically Adjusted Book per Share Related Terms


Merck Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Merck's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck Cyclically Adjusted Book per Share Chart

Merck Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 580.30 590.23 821.94 787.85

Merck Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 917.96 1,045.78 991.54 787.85 699.08

UKEX:MRK vs AMGN, ABBV, GILD: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Merck's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Merck's Cyclically Adjusted PB Ratio falls into.


UKEX:MRK
73GF Score
Merck & Co Inc UKEX:MRK
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merck Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merck's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=831.303/330.2130*330.2130
=831.303

Current CPI (Mar. 2026) = 330.2130.

Merck Quarterly Data

Book Value per Share CPI Adj_Book
201606 701.558 241.018 961.188
201609 708.837 241.428 969.511
201612 652.650 241.432 892.647
201703 650.527 243.801 881.098
201706 647.564 244.955 872.952
201709 627.793 246.819 839.909
201712 569.809 246.524 763.246
201803 559.581 249.554 740.445
201806 545.193 251.989 714.435
201809 545.710 252.439 713.838
201812 460.889 251.233 605.778
201903 477.100 254.202 619.762
201906 481.799 256.143 621.123
201909 470.822 256.759 605.515
201912 456.615 256.974 586.753
202003 464.612 258.115 594.390
202006 489.091 257.797 626.478
202009 516.290 260.280 655.009
202012 447.766 260.474 567.650
202103 476.356 264.877 593.857
202106 588.263 271.696 714.961
202109 634.295 274.310 763.561
202112 676.037 278.802 800.698
202203 723.601 287.504 831.093
202206 763.911 296.311 851.313
202209 785.314 296.808 873.699
202212 810.975 296.797 902.282
202303 825.965 301.836 903.618
202306 681.860 305.109 737.963
202309 728.034 307.789 781.075
202312 664.302 306.746 715.123
202403 713.195 312.332 754.025
202406 769.159 314.175 808.423
202409 786.518 315.301 823.716
202412 819.948 315.605 857.900
202503 859.676 319.799 887.671
202506 875.885 322.561 896.663
202509 932.846 324.800 948.392
202512 951.313 324.054 969.394
202603 831.303 330.213 831.303

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₴699.08 mean?
Merck (UKEX:MRK) has a Cyclically Adjusted Book per Share of ₴699.08 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Merck and its competitors.
Is Merck's Cyclically Adjusted Book per Share too high?
Merck's current Cyclically Adjusted Book per Share is ₴699.08. Overall, Merck has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Merck's Cyclically Adjusted Book per Share compare to AMGN and ABBV?
Merck's Cyclically Adjusted Book per Share of ₴699.08 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Merck and its competitors. Merck's current Cyclically Adjusted Book per Share is ₴699.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck stock overvalued right now?
Merck (UKEX:MRK) has a current Cyclically Adjusted Book per Share of ₴699.08. The stock's GF Value™ is ₴4,758.57, compared to a current price of ₴4,844.00 — trading 1.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is ₴699.08. Merck's overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Merck (UKEX:MRK), the current Cyclically Adjusted Book per Share is ₴699.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merck (UKEX:MRK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of ₴4,844.00 is trading 1.8% above its estimated GF Value™ of ₴4,758.57.

Key valuation signals for UKEX:MRK:

  • Cyclically Adjusted Book per Share: ₴699.08
  • GF Value™: ₴4,758.57 vs. price of ₴4,844.00 (1.8% above fair value)
  • GF Score™: 73/100 with 8 warning signs

No single metric tells the full story. See the UKEX:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
73GF Score

Get the complete analysis for UKEX:MRK

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₴4,844.00
Price
₴4,758.57
GF Value